10x Genomics Inc.

10/14/2025 | Press release | Distributed by Public on 10/14/2025 07:02

SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows

  • Automated workflows will be highlighted at ASHG 2025 with customer-generated data
  • Partnership to enable automated workflows for 10x Genomics' Chromium Single Cell Platform on SPT Labtech's firefly liquid handling platform

Melbourn, UK, and Pleasanton, California, US, 14 October 2025: SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a strategic partnership to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x's Chromium Single Cell platform, with planned future expansion to the Visium Spatial platform, by providing plug-and-play protocols on SPT Labtech's firefly® liquid handling platform.

Through this collaboration, firefly® users will gain access to optimized, ready-to-run methods developed with combined expertise from both companies' application teams. These protocols are designed to streamline single cell assay workflows, and improve reproducibility, efficiency, and scalability. This partnership builds on 10x's acquisition of Scale Biosciences, a company already partnered with SPT Labtech. Many firefly® users rely on Scale Biosciences chemistries, and this expanded collaboration with 10x will provide researchers access to the company's full range of single cell and spatial solutions.

The partnership will be spotlighted at the American Society of Human Genetics (ASHG) conference, where data from customer labs, demonstrating how automated liquid handling streamlines single-cell library prep workflows, will be presented. Development of the methods has been informed by application work conducted in customer labs with the preparation workflow addressing one of the biggest challenges in single-cell transcriptomics: scalability.

Morten Frost, Chief Commercial Officer at SPT Labtech, said: "Single cell experiments are a critical area of focus for our firefly community. Working closely with 10x Genomics has been key to understanding the specific challenges and needs of researchers in this space. By making these optimized methods available in the firefly cloud, we are empowering scientists with easier access to cutting-edge tools for single cell discovery, while reducing barriers to adoption of advanced workflows."

Brooke Murphy, Vice President, Strategic Marketing at 10x Genomics, added: "10x Genomics is committed to enabling researchers everywhere to uncover new insights into biology through our single cell solutions. This partnership with SPT Labtech will allow more labs to seamlessly automate their workflows, combining the flexibility of firefly automation with the robustness of our GEM-X chemistry, ultimately accelerating breakthroughs in human health."

SPT Labtech and 10x Genomics will exhibit (booth 2487 and 947, respectively) at ASHG, 14th - 18th October, Boston, MA, where customer data and new workflows developed will be highlighted.

Media Contact:

Dr Ben Rutter

Zyme Communications

[email protected]

To opt-out from receiving press releases from Zyme Communications please email [email protected]. To view our privacy policy please click here.

About SPT Labtech https://www.sptlabtech.com/

SPT Labtech's solutions are built to accelerate progress in genomics where demand for high-throughput and cost-effective workflows is ever-increasing. The company specializes in developing compact, user-friendly liquid handling platforms that specifically address the challenges of genomics applications, particularly in next-generation sequencing (NGS). Their flagship firefly platform simplifies complex workflows like NGS library preparation by integrating multiple functions-such as pipetting, dispensing, and incubating-into a single benchtop unit. Through strategic collaborations with key industry partners, SPT Labtech ensures its technologies are validated and optimized for a wide range of genomic chemistries, further cementing its position as a vital player in empowering genomics labs to achieve greater efficiency, reproducibility, and innovation.

About 10x Genomics https://www.10xgenomics.com/

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.

10x Genomics Inc. published this content on October 14, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 14, 2025 at 13:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]